Stay alert, beware of scamsters - know more

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Divis Laboratories Ltd Fundamentals

info2
ConsolidatedStandalone
Compare peers arrow
ConsolidatedStandalone

Market Cap

155484.95 Cr.

Face value

2.00

Book value

602.56

Div. yield

0.51%

P/E ratio

62.72

P/B ratio

9.72

Debt/Eq.

-

Market Cap

155484.95 Cr.

Face value

2.00

Book value

602.56

Div. yield

0.51%

P/E ratio

62.72

P/B ratio

9.72

Debt/Eq.

-
About Divis Laboratories Ltd
arrow

Divi’s Laboratories Limited is a Company limited by shares, incorporated and domiciled in India. The company is among the world’s leading Active Pharmaceutical Ingredient (API) manufacturers, specialising in Generic APIs, Custom Synthesis, and Nutrac Read more ▾

IndustryPharmaceuticals & Drugs
SectorHealthcare
Top subsidiaries
Divi's Laboratories (USA) IncDivi’s Laboratories Europe AG
MANAGEMENT
Whole Time Director & Chief Executive OfficerKiran S Divi
Non Executive Independent DirectorK V Chowdary
ChairmanRamesh BV Nimmagadda
Whole Time Director - CommercialNilima Prasad Divi
Executive DirectorN V Ramana
Whole Time Director - ManufacturingS Devendra Rao
Non Executive Independent DirectorS Ganapaty
Non Executive Independent DirectorRajendra Kumar Premchand
Non Executive Independent DirectorSunaina Singh
Managing DirectorMurali K Divi
Company Secretary & Compliance OfficerM Satish Choudhury
ChairmanRamesh BV Nimmagadda
Managing DirectorMurali K Divi
Executive DirectorN V Ramana
Whole Time Director & Chief Executive OfficerKiran S Divi
Whole Time Director - CommercialNilima Prasad Divi
Non Executive Independent DirectorG Suresh Kumar
Non Executive Independent DirectorR Ranga Rao
Non Executive Independent DirectorKVK Seshavataram
Non Executive Independent DirectorS Ganapaty
Non Executive Independent DirectorSunaina Singh
Non Executive Independent DirectorK V Chowdary
Company SecretarySatish Choudhury
Independent DirectorRajendra Kumar Premchand
Non Executive Independent DirectorG Suresh Kumar
ChairmanRamesh BV Nimmagadda
Whole Time Director - ProjectsMadhusudana Rao Divi
Whole Time Director - CommercialNilima Prasad Divi
Whole Time Director & Chief Executive OfficerKiran S Divi
Executive DirectorN V Ramana
Managing DirectorMurali K Divi
Non Executive Independent DirectorKVK Seshavataram
Company Secretary & Compliance OfficerSatish Choudhury
Managing DirectorMurali K Divi
Executive DirectorN V Ramana
Whole Time Director & Chief Executive OfficerKiran S Divi
Whole Time Director - ProjectsMadhusudana Rao Divi
ChairmanRamesh BV Nimmagadda
Non Executive Independent DirectorG Suresh Kumar
Non Executive Independent DirectorR Ranga Rao
Non Executive Independent DirectorKVK Seshavataram
Non Executive Independent DirectorS Ganapaty
Non Executive Independent DirectorSunaina Singh
Non Executive Independent DirectorK V Chowdary
Company Secretary & Compliance OfficerM Satish Choudhury
Whole Time Director - CommercialNilima Prasad Divi
Non Executive Independent DirectorR Ranga Rao
Non Executive Independent DirectorS Ganapaty
Non Executive Independent DirectorSunaina Singh
Non Executive Independent DirectorK V Chowdary
ChairmanRamesh BV Nimmagadda
Whole Time Director - CommercialNilima Prasad Divi
Non Executive Independent DirectorS Ganapaty
Whole Time Director & Chief Executive OfficerKiran S Divi
Executive DirectorN V Ramana
Managing DirectorMurali K Divi
Company Secretary & Compliance OfficerM Satish Choudhury
Whole Time Director - ManufacturingS Devendra Rao
Non Executive Independent DirectorSunaina Singh
Non Executive Independent DirectorRajendra Kumar Premchand
Non Executive Independent DirectorK V Chowdary
Non Executive Independent DirectorKVK Seshavataram
Other detail of Divis Laboratories Ltd
arrow
location
AddressDivi Towers, 7-1-77/E/1/303, Dharam Karan Road, Ameerpet ,Hyderabad ,Telangana-500032.
phone
Telephone040 66966300 / 400
MORE DETAILS
NSE Code10940
NSE SymbolDIVISLAB
SeriesEQ
ISININE361B01024
personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

Manufactures APIs, intermediates, and nutraceuticals, while offering custom synthesis for innovator pharma companies.

Headquartered in Hyderabad, with major manufacturing campuses in Telangana and Andhra Pradesh, plus global offices in the USA and Switzerland.

Divi’s serves 100+ countries; exports form 88% of FY25 revenue.

Revenue ₹9,550 crore; PAT ₹2,209 crore; EPS ₹83.20.

Started Unit 3 operations, added peptide synthesis capabilities, cleared US FDA inspection, and recommended ₹30/share dividend.